Connor, Clark & Lunn Investment Management »

Ovid Therapeutics shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $261k 81k 3.22
2023-09-30 $312k 81k 3.84
2023-06-30 $227k 69k 3.28
2023-03-31 $80k 31k 2.58
2022-12-31 $74k 40k 1.86
2022-09-30 $78k 43k 1.83
2022-06-30 $79k 37k 2.15
2022-03-31 $273k 87k 3.14
2021-12-31 $384k 120k 3.21
2021-09-30 $671k 200k 3.36
2021-06-30 $1.0M 258k 3.91
2021-03-31 $1.0M 252k 4.02
2020-12-31 $536k 232k 2.31
2020-09-30 $861k 150k 5.74
2020-06-30 $1.4M 190k 7.37
2020-03-31 $473k 159k 2.98